Another study on chemosensitization found that EGCG reduced ERK phosphorylation concentration-dependently, and sensitized gemcitabine, fluorouracil (5-FU), and doxorubicin to further suppress ERK phosphorylation in multiple cancer cell lines, including PC cells [137]. The gene discussed is MAPK1; the disease is cancer.